A nurse is teaching a client who has active pulmonary tuberculosis about the management of medication for the disease. Which of the following statements is appropriate for the nurse to make?
"You should report monthly to have your blood drawn to monitor kidney function while taking medication."
"You will need to take two or more medications to treat your disease."
"You should anticipate taking medication to treat your disease for at least the next 3 years."
"You will need to undergo tuberculin skin tests every 6 months while taking medication for your disease."
The Correct Answer is B
Choice A rationale: While monitoring kidney function might be necessary for some medications, it's not a routine monitoring requirement for tuberculosis medication.
Choice B rationale: Treatment for active pulmonary tuberculosis typically involves combination therapy with multiple medications to effectively target the bacteria and prevent resistance.
Choice C rationale: The duration of tuberculosis treatment varies but typically ranges from 6 to 9 months, not 3 years.
Choice D rationale: Tuberculin skin tests are used for diagnosis and not typically for monitoring treatment progress.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A rationale: Lovastatin's primary concern is not related to cardiac function to necessitate an exercise ECG.
Choice B rationale: Lovastatin belongs to a class of drugs known as statins used to lower cholesterol levels. As statins can affect liver function, monitoring liver enzymes through liver function tests is recommended before starting therapy and periodically during
treatment.
Choice C rationale: Lovastatin does not directly affect pancreatic enzymes.
Choice D rationale: Western blot analysis is a technique used for protein analysis and is not relevant to starting lovastatin therapy.
Correct Answer is D
Explanation
Choice A rationale: Exophthalmos (bulging eyes) is a characteristic feature of Graves' disease and might not directly relate to the need for a lower medication dose.
Choice B rationale: Weight loss is a symptom of hyperthyroidism and might not directly indicate the need for a lower methimazole dose.
Choice C rationale: Diaphoresis (excessive sweating) can be a symptom of hyperthyroidism but might not solely indicate the need for a lower methimazole dose.
Choice D rationale: Bradycardia (abnormally slow heart rate) might indicate excessive suppression of thyroid function caused by an excessive dose of methimazole in a client with Graves' disease, warranting a lower medication dose.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.